XPH

SPDR S&P Pharmaceuticals ETF

Down$36.30
$-0.28
(-0.77%)
As of 6:40:00 PM EDT | 8/20/19  |  Market Closed

XPH Trading Data

Open

$36.49

Low Price

$36.3

High Price

$36.81

Previous Last Price

$36.58

Bid Size

$34.56 X 100

Ask Size

$39.56 X 500

XPH Portfolio Data

AUM

$192,052,300

Shares

5,250

PE Ratio

10.28

Price / Book Ratio

2.43

Expense Ratio

0.35

Net Asset Value

$36.58

Volume

Volume

18,300

Avg. Volume (YDT)

57,623

Dollar Volume

$1,227,936

Weekly Avg. Volume

67,600

Monthly Avg. Volume

60,075

Quarterly Avg. Volume

52,683

XPH Fund Description

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

XPH Chart

XPH Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Pharmaceuticals ETF

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

XPH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XPH Holdings

Top 10 Holdings

Allergan plc (AGN)
6.35%
Horizon Therapeutics Public Limited Company (HZNP)
5.34%
Zoetis Inc. Class A (ZTS)
5.27%
Mylan N.V. (MYL)
5.07%
Perrigo Co. Plc (PRGO)
4.98%
Jazz Pharmaceuticals Plc (JAZZ)
4.81%
Merck & Co. Inc. (MRK)
4.78%
Eli Lilly and Company (LLY)
4.6%
Bristol-Myers Squibb Company (BMY)
4.6%
Johnson & Johnson (JNJ)
4.36%

Total XPH Holdings

Total Holdings: 43

Allergan plc (AGN)
6.35%
Horizon Therapeutics Public Limited Company (HZNP)
5.34%
Zoetis Inc. Class A (ZTS)
5.27%
Mylan N.V. (MYL)
5.07%
Perrigo Co. Plc (PRGO)
4.98%
Jazz Pharmaceuticals Plc (JAZZ)
4.81%
Merck & Co. Inc. (MRK)
4.78%
Eli Lilly and Company (LLY)
4.6%
Bristol-Myers Squibb Company (BMY)
4.6%
Johnson & Johnson (JNJ)
4.36%
Elanco Animal Health Inc. (ELAN)
4.28%
Catalent Inc (CTLT)
3.96%
Pfizer Inc. (PFE)
3.77%
MyoKardia Inc. (MYOK)
3.41%
Zogenix Inc. (ZGNX)
3.33%
Nektar Therapeutics (NKTR)
2.52%
Axsome Therapeutics Inc. (AXSM)
2.51%
Pacira Biosciences Inc. (PCRX)
2.07%
Reata Pharmaceuticals Inc. Class A (RETA)
2.04%
Supernus Pharmaceuticals Inc. (SUPN)
1.83%
Mallinckrodt Plc (MNK)
1.72%
Aerie Pharmaceuticals Inc. (AERI)
1.72%
Prestige Consumer Healthcare Inc (PBH)
1.6%
Endo International Plc (ENDP)
1.56%
TherapeuticsMD Inc. (TXMD)
1.48%
Corcept Therapeutics Incorporated. (CORT)
1.24%
Innoviva Inc. (INVA)
1.13%
Omeros Corporation (OMER)
1.12%
Tricida Inc (TCDA)
0.99%
Wave Life Sciences Ltd. (WVE)
0.97%
CymaBay Therapeutics Inc. (CBAY)
0.94%
Theravance Biopharma Inc (TBPH)
0.83%
ANI Pharmaceuticals Inc. (ANIP)
0.7%
Intersect ENT Inc (XENT)
0.64%
Collegium Pharmaceutical Inc. (COLL)
0.6%
Phibro Animal Health Corporation Class A (PAHC)
0.55%
Akorn Inc. (AKRX)
0.55%
Revance Therapeutics Inc. (RVNC)
0.53%
Amneal Pharmaceuticals Inc. Class A (AMRX)
0.38%
Amphastar Pharmaceuticals Inc (AMPH)
0.37%
Intra-Cellular Therapies Inc. (ITCI)
0.33%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.16%
SPDR S & P Pharmaceuticals ETF (XPH)
0%

XPH Technicals

Alpha

-14.62

Beta

1.35

Leverage

Long

Standard Deviation

3.58

XPH Dividends

Dividend Date

2019-06-24

Latest Dividend

0.068

Annual Dividend

0.3

Annual Dividend Rate

0.3

Annual Dividend Yield

0.81

XPH Performance

YTD Return

-0.87%

1 Year Return

-26.4%

3 Year Return

-19.4%

5 Year Return

-30.13%

10 Year Return

121.27%

XPH Related Articles

4 Hot Pharmaceutical ETFs

4 Hot Pharmaceutical ETFs

Pharmaceutical ETFs invest in stocks of companies that are involved in the research, development, manufacture, sale or distribution of pharmaceuticals…